
April 14 (Reuters) - Cue Biopharma Inc CUE.O:
BOEHRINGER INGELHEIM AND CUE BIOPHARMA PARTNER TO DEVELOP TREATMENT FOR AUTOIMMUNE AND INFLAMMATORY DISEASES
CUE BIOPHARMA INC: UNDER COLLABORATION, CO TO RECEIVE UP-FRONT PAYMENT OF $12 MILLION AS WELL AS RESEARCH SUPPORT PAYMENTS
CUE BIOPHARMA INC: CO IS ALSO ELIGIBLE TO EARN UP TO ABOUT $345 MILLION IN MILESTONE-BASED PAYMENTS